<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In Europe and the United States, the incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has increased 6-fold in the last 25 years and currently accounts for more than 50% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is the source of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and is characterized by the replacement of squamous epithelium with columnar epithelium in the lower esophagus due to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Even though the prevalence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> has recently been increasing in Japan as well as in Europe and the United States, the clinical situation of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> differs from that in Western countries </plain></SENT>
<SENT sid="3" pm="."><plain>In this paper, we focus on specific differences in the background factors and pathophysiology of these lesions </plain></SENT>
</text></document>